Lessons learned from applying established cut-off values of questionnaires to detect somatic symptom disorders in primary care: a cross-sectional study
Victoria von Schrottenberg,Anne Toussaint,Alexander Hapfelmeier,Clara Teusen,Bernhard Riedl,Peter Henningsen,Jochen Gensichen,Antonius Schneider,Klaus Linde,Tobias Dreischulte,Peter Falkai,Jochen Gensichen,Peter Henningsen,Markus Bühner,Caroline Jung-Sievers,Helmut Krcmar,Karoline Lukaschek,Gabriele Pitschel-Walz,Antonius Schneider,Jochen Vukas,Puya Younesi,Feyza Gökce,Victoria von Schrottenberg,Petra Schönweger,Hannah Schillock,Jonas Raub,Philipp Reindl-Spanner,Lisa Hattenkofer,Lukas Kaupe,Carolin Haas,Julia Eder,Vita Brisnik,Constantin Brand,Chris Ebert,Marie Emilia Vogel,Clara Teusen,Katharina Biersack
DOI: https://doi.org/10.3389/fpsyt.2023.1289186
IF: 4.7
2024-01-19
Frontiers in Psychiatry
Abstract:Introduction: Based on two diagnostic accuracy studies in high-prevalence settings, two distinctly different combinations of cut-off values have been recommended to identify persons at risk for somatic symptom disorder (SSD) with the combination of the Patient-Health Questionnaire-15 (PHQ-15) and the Somatic Symptom Disorder—B Criteria Scale (SSD-12). We investigated whether the reported sensitivity and specificity of both recommended cut-off combinations are transferable to primary care. Methods: In a cross-sectional study, 420 unselected adult primary care patients completed PHQ-15 and SSD-12. Patients scoring ≥9 and ≥ 23 (recommended cut-off combination #1) or ≥ 8 and ≥ 13 (recommended cut-off combination #2) were considered test-positive for SSD, respectively. To assess the validity of the reported sensitivity and specificity in different low- to high-prevalence settings, we compared correspondingly expected proportions of test positives to the proportion observed in our sample. Results: Based on combination #1, 38 participants (9%) were found to be test positive, far fewer than expected, based on the reported values for sensitivity and specificity (expected minimum frequency 30% with a true prevalence ≥1%). This can only be explained by a lower sensitivity and higher specificity in primary care. For combination #2, 98 participants (23%) were test positive, a finding consistent with a true prevalence of SSD of 15% or lower. Discussion: Our analyzes strongly suggest that the sensitivity and specificity estimates reported for combination #1 are not applicable to unselected primary care patients and that the cut-off for the SSD (≥23) is too strict. Cut-off combination #2 seems more applicable but still needs to be tested in studies that compare screening findings by questionnaires with validated diagnostic interviews as reference standards in primary care populations.
psychiatry